2010 - TTS International Congress


This page contains exclusive content for the member of the following sections: TTS. Log in to view.

Epidemiology and Clinical Outcomes

100.7 - The Evolving Outcomes of Kidney Transplant Recipients Over 70 Years of Age

Presenter: Islam, Ghoneim, Cleveland, United States
Authors: Ghoneim I., Tiong H., Schold J., Srinivas T., Modlin C., Goldfarb D., Flechner S.

THE EVOLVING OUTCOMES OF KIDNEY TRANSPLANT RECIPIENTS OVER 70 YEARS OF AGE

EPIDEMIOLOGY AND CLINICAL OUTCOMES

I.A. Ghoneim1, H.Y. Tiong1, J.D. Schold1, T. Srinivas1, C.S. Modlin2, D. Goldfarb1, S.M. Flechner1
1Glickman Urological And Kidney Institute, Cleveland Clinic Foundation, Cleveland/UNITED STATES OF AMERICA, 2Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland/UNITED STATES OF AMERICA

Body: Introduction: Prior to 2000 only 2 patients over age 70 years had received a kidney transplant at our center. This age limit restriction was based anecdotal reports of excess morbidity and mortalityfor this group. Since 2000, > age 70 represents 3.5% of our recipients, up to 6.3% the past 2 years. The annual mortality of such patients on dialysis exceeds 20%, which drives the desire forrenal transplantation in this population.

Methods: The CCF Unified Transplant Database was queried for all kidney-only transplant recipients age 70 years or older at transplant. There were 49 patients with a mean age of 72.5 (range 70-86)years including 34 males and 15 females. The cause of ESRD included GN 33%; HTN 22%; DM 12%, PKD 6%, Unknown 15%. The Donor Source included DD 67%; LRD 22%: and LUR 10%. The mean BMI was 27 kg/m2.Immunosuppression included mycophenolate mofetil and steroids with a CNI drug in 53.1% or an mTOR in 38.7% of cases. These outcomes were then compared to the SRTR national database during the lastdecade.

Results: The mean FU is 37.7 (range 1-92) months. Kaplan-Meier survivals (%) at 1,3, 5 years, respectively are for Patient Survival (86, 72, and 56). For Graft Survival -uncensored (86, 72, 56) vs.Graft-death censored (97, 94, 88). Among 14 deaths the causes were CV 50%; Infectious 14%; Pulmonary 14%; and Unknown (out of hospital) 21%. One year biopsy confirmed acute rejection was 6%, and themean creatinine was 1.25 mg/dL. There were 3 cases of de novo skin or solid organ cancers. These outcomes are quite similar at our center compared to the national registry. Nationally, the proportionof patients > 70 in the past three years is 6% (an increase from 2.7% in the prior decade). The 1, 3, and 5 yr overall and death censored graft survival rates are (87, 75, 66) and (94, 90, 88),respectively.

Conclusions: Patients over age 70 are seeking the option of kidney transplantation in greater numbers today. Their transplant outcomes are primarily driven by an increased rate of cardiovascularmortality the first 3 years. They exhibit relatively low rates of rejection, infection, and have excellent post transplant renal function. Pretransplant functional capacity and CV status are the bestpredictors of outcome, and therefore careful selection and wait list assessment of their status is essential.

Disclosure: All authors have declared no conflicts of interest.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada